Calpain-2 Inhibitor Therapy Reduces Murine Colitis and Colitis-associated Cancer. | Profiles RNS

RCMI Coordinating Center (RCMI CC)

Calpain-2 Inhibitor Therapy Reduces Murine Colitis and Colitis-associated Cancer.

Rose AH, Huang Z, Mafnas C, Hara JH, Hoffmann FW, Hashimoto AS, Bertino P, Hoffmann PR. Calpain-2 Inhibitor Therapy Reduces Murine Colitis and Colitis-associated Cancer. Inflamm Bowel Dis. 2015 Sep; 21(9):2005-15.

View in: PubMed

authors with profiles

Peter R. Hoffmann, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support